Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| G1 Therapeutics, Inc. | 3,279,421 | reported | 30 May 2018 | tx 18+4,173,729−12,319,360 |
| Clearside Biomedical, Inc. | 2,060,514 | reported | 19 Jan 2017 | tx 3−29,656 |
| TETRALOGIC PHARMACEUTICALS CORP | 30,000 | reported | 28 Jan 2015 | tx 8+1,219,742−1,066,885 |
| DIGIRAD CORP | 14,760 | reported | 22 Apr 2008 | tx 36+2,213,427−4,325,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 30 May 2018 | SALE | G1 Therapeutics, Inc. | 758,290 | 48.00 USD | anomaly |
| 30 May 2018 | SALE | G1 Therapeutics, Inc. | 41,710 | 48.00 USD | |
| 23 May 2018 | SALE | G1 Therapeutics, Inc. | 26 | 50.50 USD | |
| 21 May 2018 | SALE | G1 Therapeutics, Inc. | 29,005 | 51.16 USD | |
| 21 May 2018 | SALE | G1 Therapeutics, Inc. | 1,595 | 51.06 USD | |
| 23 May 2018 | SALE | G1 Therapeutics, Inc. | 474 | 50.50 USD | |
| 22 May 2018 | SALE | G1 Therapeutics, Inc. | 308 | 50.69 USD | |
| 22 May 2018 | SALE | G1 Therapeutics, Inc. | 5,592 | 50.86 USD | |
| 21 May 2018 | SALE | G1 Therapeutics, Inc. | 26 | 52.13 USD | |
| 21 May 2018 | SALE | G1 Therapeutics, Inc. | 474 | 52.13 USD | |
| 22 May 2017 | CONVERSION | G1 Therapeutics, Inc. | 99,513 | — | |
| 22 May 2017 | PURCHASE | G1 Therapeutics, Inc. | 133,333 | 15.00 USD | first after silence |
| 22 May 2017 | CONVERSION | G1 Therapeutics, Inc. | 3,728,464 | — | |
| 22 May 2017 | CONVERSION | G1 Therapeutics, Inc. | 212,419 | — | |
| 22 May 2017 | CONVERSION | G1 Therapeutics, Inc. | 1,318,681 | — | deriv |
| 22 May 2017 | CONVERSION | G1 Therapeutics, Inc. | 2,584,959 | — | deriv |
| 22 May 2017 | CONVERSION | G1 Therapeutics, Inc. | 1,009,693 | — | deriv |
| 22 May 2017 | CONVERSION | G1 Therapeutics, Inc. | 6,568,527 | — | deriv |
| 17 Jan 2017 | SALE | Clearside Biomedical, Inc. | 9,806 | 8.92 USD | |
| 18 Jan 2017 | SALE | Clearside Biomedical, Inc. | 12,258 | 8.64 USD | |
| 19 Jan 2017 | SALE | Clearside Biomedical, Inc. | 7,592 | 8.22 USD | |
| 28 Jan 2015 | GRANT_AWARD | TETRALOGIC PHARMACEUTICALS CORP | 10,000 | 5.25 USD | deriv |
| 17 Dec 2013 | CONVERSION | TETRALOGIC PHARMACEUTICALS CORP | 278,315 | 7.00 USD | |
| 17 Dec 2013 | PURCHASE | TETRALOGIC PHARMACEUTICALS CORP | 142,857 | 7.00 USD | |
| 17 Dec 2013 | EXERCISE | TETRALOGIC PHARMACEUTICALS CORP | 7,590 | 6.40 USD |
1 purchase reported after at least 12 months of silence — most recent on 22 May 2017.